{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicdjfbaamlz7mh4zwovfectzj5xi4s5bvfpsj4oazdvs2k6a3lkra",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mo6qt4usugt2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicc5dbgige4stsybka7fljgljjwq42o37744l27nmgvjr7jjrxow4"
    },
    "mimeType": "image/jpeg",
    "size": 200232
  },
  "path": "/news/2026-06-day-pill-weight-loss-phase.html",
  "publishedAt": "2026-06-13T11:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist called Elecoglipron, which could offer the weight-loss benefits of GLP-1 therapy without injections.",
  "title": "Could a once-a-day pill replace weight loss injections? Phase II oral GLP-1 drug trial shows promising results"
}